Why we are here?

Our vision - to be the clear choice

Our vision is to become an integrated global pharmaceutical company adhering to high standards of quality and compliance

Our mission - the higher purpose

Kimia’s tag line “Chemistry of well-being” speaks volumes about the founders’ mission to leverage chemistry for the wellbeing of the people across the globe.

What we believe in?




Invent and pioneer
for human well being


Excellence in
everything we do




Improving planet


Being honest and

What we want to be?

The Clear Choice


Our customer value
associating with us


Our people want to
invest their careers with us


Our communities
trust us

How will we reach there?


Constant investment in R&D for innovation


Stringent quality


Making our processes agile for faster value delivery


Nurture and develop our people capabilities


Expanding product and service ecosystem with strategic partnerships


Embracing sustainable practices to reduce environmental impact

Our Promise

With the purpose of human wellbeing we deliver high quality chemistry solutions,
by blending our customer centric approach with agile production and delivery processes.

Our journey

The secret of a bright future is crafted in the womb of history!

Started R&D and ramped up with 120 people with strong IPR team


Acquisition of Laurel Organics limited, a listed company in 2016.


Accreditation of who GMP in 2019 and DSIR R&D in 2017.


Filed KDMF for 2 key products, Benfotiamine and Fimasartan Potassium Hydrochloride.


Commenced export business in Pakistan 2017 and quickly ramped up exports to more than 15 countries between 2018-2020 and successfully exported to the US in 2021.


Upgraded facility with 2 modern Microbiology labs, Water System, 5 clean room and In house micronization.


Ramped up exports to more than 15 countries


Successfully exported to the US



Mr. Sameer Goel

Managing Director (MD)

Mr. Sameer Goel is the Managing Director and heading Kimia Biosciences. He holds a tall stature in the Indian API market and has strong multi-dimensional capabilities in the areas of Business Development, Product Development, Strategic Marketing and Operations Management. He has played a key leadership role with various organizations in acquiring and aligning the strong support of professional networks, business partners and executive teams to accomplish expertise in manufacturing, sales, marketing and trading of various APIs and its Intermediates.

Currently, Mr. Goel is responsible for providing overall leadership in achieving business & product development goals and formation of strategic partnerships in Business.

Mr. Lakshay Prakash

Company Secretary

We are pleased to announce the appointment of Mr. Lakshay Prakash joining us as Company Secretary effective 16th May 2022 at Kimia Biosciences Ltd. Lakshay will lead legal & Company Secretarial activities, liasoning with various government bodies and handling the legal & company secretarial matters. He shall be directly reporting into The Chief Financial Officer and till such time the CFO is onboarded, he will work in close unison with the M.D and C.E.O.

He brings to the Organization more than 6 years of experience in Secretarial & Legal Compliance. Lakshay is well versed with compliances under companies act , LLP, SEBI Regulations, Listing Regulations, FEMA . Prior to joining Kimia Biosciences Ltd., he was associated with Integrated Capital Services Limited .

Lakshay is a qualified LLB from Chaudhary Charan Singh University in 2017 followed by C.S from Institute of Company Secretary of India in 2015.

Lakhsay is Married to Ms. Prerna who is an Educator and has been recently blessed with a baby girl Kinaisha. He has keen interest in Reading.

Dr. Rita Sarin

Advisor – Strategy & IPR Head of Intellectual Property Rights

Dr. Rita Sarin is an Advisor and heading IPR and Strategic Management at Kimia Biosciences Ltd. She is Ph.D. degree in Medicinal Chemistry from Central Drug Research Institute (CDRI), Lucknow and has 24 years of extensive experience in various aspects of Intellectual Property. She has previously worked at Ranbaxy (now Sun Pharma) and Lupin Research Laboratories. She has received an award from the President of India, late Shri Dr. Abdul Kalam Azad in 2012 for the launch of Synriam TM, the first drug developed in India.

974, Aggarwal Millennium Tower II,
Netaji Subhash Place, Pitampura,
New Delhi-110 034
+91-11-4706 3600

Kimia Biosciences Ltd™ is engaged in manufacturing of bulk drugs addressing to various high potential therapeutic segments and has envisaged high growth plans through infrastructure creation and CMS.